Severe psychiatric illnesses affect one in 20 American adults, creating immense medical, social, and economic strains, while Stanford Medicine researchers have successfully transplanted laboratory-grown human cortical organoids into mice with bioengineered cerebral cortex deficiencies.
Stanford Researchers Transplant Human Brain Tissue into Mice
Published online in Nature, a study details how researchers successfully placed self-organizing clusters of human brain tissue—known as cortical organoids—into mice that were specifically bioengineered and bred to lack almost all of their cerebral cortex. The cerebral cortex serves as the outermost rind of the brain, governing higher-level functions such as cognition, language, attention, and decision-making. Scientists at Stanford Medicine have advanced the study of human brain tissue growth by moving beyond traditional laboratory glassware.
According to Stanford Medicine reporting, the transplanted organoids not only survived and thrived but also grew and formed working connections with the mouse brain and further down to the spinal cord. The vast cavity left in the engineered mouse brains provided a hospitable environment where the human tissue could take root. This integration offers researchers a view of human neural circuitry operating inside a living, intact mammalian nervous system.
According to Sergiu Pasca, these animal models present an exceptional chance to investigate the ways that pathology-linked changes in human neural pathways express themselves within an operating nervous system.
Rare Nerve Cells Found in New Xenocortical Mouse Models
Within these xenocortical mice, the research team made an unexpected discovery: they identified a distinct nerve-cell type that had never before been observed in laboratory cell cultures and had previously been documented only in autopsied human brains. This capability stems from over a decade of methodical laboratory development, which began when scientists first learned to convert human skin cells into stem cells capable of differentiating into diverse cell types.
Schizophrenia, which is believed to originate from brain-circuit abnormalities established before birth, impacts more than 1 in 100 adults, while roughly 1% of the population experiences lifelong epilepsy. The methodology is designed to accelerate investigation into the biological origins of complex psychiatric and neurological conditions.
Alison Singer, president of the patient-advocacy group Autism Science Foundation, noted that one in every 218 American children meets the criteria for profound autism. This diagnosis describes individuals facing pronounced cognitive challenges who require continuous supervision and hands-on help with daily routines. The stakes are equally high for children facing severe developmental conditions.
Alison Singer stated that profoundly autistic patients have pronounced cognitive disabilities, with measured IQs below 50, noting that they are vulnerable to sleep disorders, epilepsy and self-injury, and are disproportionally likely to exhibit aggressive behavior.
Addressing Oxygen Deprivation and Cerebral Palsy in Brain Research
Depriving these cells of oxygen during pregnancy or around the time of birth is a recognized trigger for cerebral palsy, a condition affecting 3 in 1,000 Americans that also serves as a known risk factor for epilepsy and autism. Beyond psychiatric conditions, the research model addresses the vulnerability of human cerebral nerve cells to oxygen deprivation.
By juxtaposing different regional organoids in the laboratory to stimulate complex signaling circuits, researchers have created a platform to evaluate interventions before birth-related or developmental disorders manifest fully. Study leaders emphasize that while traditional animal models remain useful, certain biological characteristics remain distinctly human.
Sergiu Pasca pointed out that investigators will gain deeper insights into the origins and pathways of neurodevelopmental and gestational conditions, while also gaining the ability to evaluate potential therapies aimed at reversing or stopping them.
